药物坚持和心力衰竭中的健康状况与减少喷射小部分的关联:来自CHAMP-HF注册表的见解
Rayan S El-Zein1, Moghniuddin Mohammed1,2, Daniel D Nguyen1
1University of Missouri - Kansas City's Healthcare Institute for Innovation in Quality and Saint Luke's Mid America Heart Institute, Kansas City (R.S.E.-Z., M.M., D.D.N., M.N., J.A.S.).
Circulation. Cardiovascular quality and outcomes
|July 24, 2024
概括
在心力衰竭中,减少喷射分数 (HFrEF) 的药物不服药与健康状况不佳和改善程度较低有关. 改善对指导方针导向医疗治疗的坚持可以提高患者的健康状况.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 患者的健康结果.
背景情况:
- 遵循指导方针医疗疗法 (GDMT) 是减少喷射率心力衰竭 (HFrEF) 管理的基础.
- 将药物坚持与患者的健康状况 (症状,功能,生活质量) 联系起来可以强调其重要性.
研究的目的:
- 调查美国门诊患者与HFrEF的自我报告的药物坚持和健康状况之间的关联.
- 在12个月的时间内分析坚持的变化及其与健康状况的相关性.
主要方法:
- 分析来自改变心力衰竭患者管理登记 (2015-2017) 的数据.
- 使用4项Morisky-Green-Levine药物坚持度表 (≥1表示不坚持) 评估的药物坚持.
- 通过堪萨斯城心肌病问卷总体总结得分 (KCCQ-OS) 测量健康状况;用于分析的强大的线性回归模型.
主要成果:
- 在3495名HFrEF患者中,31.7%的人报告不坚持.
- 与坚持患者相比,非坚持患者的健康状况在基线较差,并在12个月后改善较少.
- 在最初不坚持的患者中,那些改善了坚持的人倾向于更好地改善6个月的健康状况.
结论:
- 在HFrEF中,不服药与更糟糕的健康状况和随着时间的推移而减少的改善显著相关.
- 提高药物坚持对于改善HFrEF患者的健康状况至关重要.
- 支持遵守GDMT对于优化HFrEF患者的治疗结果至关重要.
相关概念视频
01:17Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
414
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
414
01:22Heart Failure Drugs: β-Blockers
333
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
333
01:22Heart Failure Drugs: Diuretics
356
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
356
01:26Heart Failure Drugs: Inotropic Agents
559
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
559
01:26Imbalances in Cardiac Output
1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K